These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28686208)

  • 1. Structural Elements Recognized by Abacavir-Induced T Cells.
    Yerly D; Pompeu YA; Schutte RJ; Eriksson KK; Strhyn A; Bracey AW; Buus S; Ostrov DA
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28686208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
    Illing PT; Vivian JP; Dudek NL; Kostenko L; Chen Z; Bharadwaj M; Miles JJ; Kjer-Nielsen L; Gras S; Williamson NA; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
    Nature; 2012 Jun; 486(7404):554-8. PubMed ID: 22722860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.
    Norcross MA; Luo S; Lu L; Boyne MT; Gomarteli M; Rennels AD; Woodcock J; Margulies DH; McMurtrey C; Vernon S; Hildebrand WH; Buchli R
    AIDS; 2012 Jul; 26(11):F21-9. PubMed ID: 22617051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Abacavir-Induced Structural Alterations in Human Leukocyte Antigen-B*57 : 01 Using Phage Display.
    Shirayanagi T; Aoki S; Fujimori S; Watanabe K; Aida T; Hirasawa M; Kumagai K; Hoshino T; Ito K
    Biol Pharm Bull; 2020; 43(6):1007-1015. PubMed ID: 32475910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity Syndrome.
    Fodor J; Riley BT; Kass I; Buckle AM; Borg NA
    Sci Rep; 2019 Jul; 9(1):10523. PubMed ID: 31324847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.
    Adam J; Wuillemin N; Watkins S; Jamin H; Eriksson KK; Villiger P; Fontana S; Pichler WJ; Yerly D
    PLoS One; 2014; 9(4):e95339. PubMed ID: 24751900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced alloreactivity: A new paradigm for allorecognition.
    D'Orsogna LJ; Almeida CM; van Miert P; Zoet YM; Anholts JDH; Chopra A; Watson M; Witt C; John M; Claas FHJ
    Am J Transplant; 2019 Sep; 19(9):2606-2613. PubMed ID: 31125485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cells from HLA-B*57:01+ human subjects are activated with abacavir through two independent pathways and induce cell death by multiple mechanisms.
    Bell CC; Faulkner L; Martinsson K; Farrell J; Alfirevic A; Tugwood J; Pirmohamed M; Naisbitt DJ; Park BK
    Chem Res Toxicol; 2013 May; 26(5):759-66. PubMed ID: 23541086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sharing of four DR-beta sequence motifs between HLA-DRB1*1601 and DRB1*1101 correlates with frequent degenerate T-cell recognition of HA306-320 peptide complexed to these two molecules.
    Zeliszewski D; Dorval I; Golvano JJ; Prevost A; Borras-Cuesta F; Sterkers G
    Scand J Immunol; 1996 Feb; 43(2):146-54. PubMed ID: 8633194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation.
    Thomson PJ; Illing PT; Farrell J; Alhaidari M; Bell CC; Berry N; O'Neill PM; Purcell AW; Park KB; Naisbitt DJ
    Allergy; 2020 Mar; 75(3):636-647. PubMed ID: 31549414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors.
    Sooda A; Rwandamuriye F; Wanjalla CN; Jing L; Koelle DM; Peters B; Leary S; Chopra A; Calderwood MA; Mallal SA; Pavlos R; Watson M; Phillips EJ; Redwood AJ
    Commun Biol; 2022 Feb; 5(1):133. PubMed ID: 35173258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire.
    Illing PT; van Hateren A; Darley R; Croft NP; Mifsud NA; King S; Kostenko L; Bharadwaj M; McCluskey J; Elliott T; Purcell AW
    Front Immunol; 2021; 12():672737. PubMed ID: 34093574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Zhou P; Zhang S; Wang Y; Yang C; Huang J
    J Biomol Struct Dyn; 2016 Aug; 34(8):1806-17. PubMed ID: 26488421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.
    Geluk A; van Meijgaarden KE; Ottenhoff TH
    Immunology; 1997 Mar; 90(3):370-5. PubMed ID: 9155643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell allorecognition via molecular mimicry.
    Macdonald WA; Chen Z; Gras S; Archbold JK; Tynan FE; Clements CS; Bharadwaj M; Kjer-Nielsen L; Saunders PM; Wilce MC; Crawford F; Stadinsky B; Jackson D; Brooks AG; Purcell AW; Kappler JW; Burrows SR; Rossjohn J; McCluskey J
    Immunity; 2009 Dec; 31(6):897-908. PubMed ID: 20064448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule.
    Liu YC; Miles JJ; Neller MA; Gostick E; Price DA; Purcell AW; McCluskey J; Burrows SR; Rossjohn J; Gras S
    J Biol Chem; 2013 May; 288(22):15442-54. PubMed ID: 23569211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of drug allergy--current concepts and recent insights.
    Schnyder B; Brockow K
    Clin Exp Allergy; 2015 Sep; 45(9):1376-83. PubMed ID: 26172398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.
    Ostrov DA; Grant BJ; Pompeu YA; Sidney J; Harndahl M; Southwood S; Oseroff C; Lu S; Jakoncic J; de Oliveira CA; Yang L; Mei H; Shi L; Shabanowitz J; English AM; Wriston A; Lucas A; Phillips E; Mallal S; Grey HM; Sette A; Hunt DF; Buus S; Peters B
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9959-64. PubMed ID: 22645359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation.
    Naisbitt DJ; Yang EL; Alhaidari M; Berry NG; Lawrenson AS; Farrell J; Martin P; Strebel K; Owen A; Pye M; French NS; Clarke SE; O'Neill PM; Park BK
    AIDS; 2015 Nov; 29(18):2385-95. PubMed ID: 26372480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.